Ardent Health, Inc. — Form 8-K
Filed September 4, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Ardent Health filed an 8-K amending only Item 7 (MD&A) of its 2025 Form 10-K (filed March 16, 2026) to revise and clarify supplemental non-GAAP performance and valuation measures. The company detailed Adjusted EBITDA ($447.3M in 2025, down from $498.5M in 2024) and Adjusted EBITDAR ($611.6M in 2025, annualized), with reconciliations to GAAP net income ($230.1M). Key adjustments include REIT rent expense ($164.3M annually—primarily Ventas Master Lease $152.9M plus MPT $11.4M for 12 leased hospitals and 18 medical office buildings), Epic system implementation costs ($4.8M in 2025), restructuring/severance ($10.3M in 2025), and cybersecurity incident net recoveries ($22.7M in 2025). No changes to core business operations, financials, or other 10-K sections were disclosed.
Why this rating
Routine MD&A clarification of non-GAAP definitions and reconciliations. No material business, financial, or operational changes disclosed. Filing is administrative restatement.
See more from September 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.